<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1995-11-01" modified="2020-10-07" version="220">
<accession>P46060</accession>
<accession>Q96JJ2</accession>
<name>RAGP1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Ran GTPase-activating protein 1</fullName>
<shortName>RanGAP1</shortName>
</recommendedName>
</protein>
<gene>
<name type="primary">RANGAP1</name>
<name type="synonym">KIAA1835</name>
<name type="synonym">SD</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1995" name="Proc. Natl. Acad. Sci. U.S.A." volume="92" first="1749" last="1753">
<title>Human RanGTPase-activating protein RanGAP1 is a homologue of yeast Rna1p involved in mRNA processing and transport.</title>
<authorList>
<person name="Bischoff F.R."/>
<person name="Krebber H."/>
<person name="Kempf T."/>
<person name="Hermes I."/>
<person name="Ponstingl H."/>
</authorList>
<dbReference type="PubMed" id="7878053"/>
<dbReference type="DOI" id="10.1073/pnas.92.5.1749"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2001" name="DNA Res." volume="8" first="85" last="95">
<title>Prediction of the coding sequences of unidentified human genes. XX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.</title>
<authorList>
<person name="Nagase T."/>
<person name="Nakayama M."/>
<person name="Nakajima D."/>
<person name="Kikuno R."/>
<person name="Ohara O."/>
</authorList>
<dbReference type="PubMed" id="11347906"/>
<dbReference type="DOI" id="10.1093/dnares/8.2.85"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2002" name="DNA Res." volume="9" first="99" last="106">
<title>Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.</title>
<authorList>
<person name="Nakajima D."/>
<person name="Okazaki N."/>
<person name="Yamakawa H."/>
<person name="Kikuno R."/>
<person name="Ohara O."/>
<person name="Nagase T."/>
</authorList>
<dbReference type="PubMed" id="12168954"/>
<dbReference type="DOI" id="10.1093/dnares/9.3.99"/>
</citation>
<scope>SEQUENCE REVISION</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Biol." volume="5" first="R84.1" last="R84.11">
<title>A genome annotation-driven approach to cloning the human ORFeome.</title>
<authorList>
<person name="Collins J.E."/>
<person name="Wright C.L."/>
<person name="Edwards C.A."/>
<person name="Davis M.P."/>
<person name="Grinham J.A."/>
<person name="Cole C.G."/>
<person name="Goward M.E."/>
<person name="Aguado B."/>
<person name="Mallya M."/>
<person name="Mokrab Y."/>
<person name="Huckle E.J."/>
<person name="Beare D.M."/>
<person name="Dunham I."/>
</authorList>
<dbReference type="PubMed" id="15461802"/>
<dbReference type="DOI" id="10.1186/gb-2004-5-10-r84"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1999" name="Nature" volume="402" first="489" last="495">
<title>The DNA sequence of human chromosome 22.</title>
<authorList>
<person name="Dunham I."/>
<person name="Hunt A.R."/>
<person name="Collins J.E."/>
<person name="Bruskiewich R."/>
<person name="Beare D.M."/>
<person name="Clamp M."/>
<person name="Smink L.J."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Babbage A.K."/>
<person name="Bagguley C."/>
<person name="Bailey J."/>
<person name="Barlow K.F."/>
<person name="Bates K.N."/>
<person name="Beasley O.P."/>
<person name="Bird C.P."/>
<person name="Blakey S.E."/>
<person name="Bridgeman A.M."/>
<person name="Buck D."/>
<person name="Burgess J."/>
<person name="Burrill W.D."/>
<person name="Burton J."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chen Y."/>
<person name="Clark G."/>
<person name="Clegg S.M."/>
<person name="Cobley V.E."/>
<person name="Cole C.G."/>
<person name="Collier R.E."/>
<person name="Connor R."/>
<person name="Conroy D."/>
<person name="Corby N.R."/>
<person name="Coville G.J."/>
<person name="Cox A.V."/>
<person name="Davis J."/>
<person name="Dawson E."/>
<person name="Dhami P.D."/>
<person name="Dockree C."/>
<person name="Dodsworth S.J."/>
<person name="Durbin R.M."/>
<person name="Ellington A.G."/>
<person name="Evans K.L."/>
<person name="Fey J.M."/>
<person name="Fleming K."/>
<person name="French L."/>
<person name="Garner A.A."/>
<person name="Gilbert J.G.R."/>
<person name="Goward M.E."/>
<person name="Grafham D.V."/>
<person name="Griffiths M.N.D."/>
<person name="Hall C."/>
<person name="Hall R.E."/>
<person name="Hall-Tamlyn G."/>
<person name="Heathcott R.W."/>
<person name="Ho S."/>
<person name="Holmes S."/>
<person name="Hunt S.E."/>
<person name="Jones M.C."/>
<person name="Kershaw J."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Laird G.K."/>
<person name="Langford C.F."/>
<person name="Leversha M.A."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Martyn I.D."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L.H."/>
<person name="Mccann O.T."/>
<person name="Mcclay J."/>
<person name="Mclaren S."/>
<person name="McMurray A.A."/>
<person name="Milne S.A."/>
<person name="Mortimore B.J."/>
<person name="Odell C.N."/>
<person name="Pavitt R."/>
<person name="Pearce A.V."/>
<person name="Pearson D."/>
<person name="Phillimore B.J.C.T."/>
<person name="Phillips S.H."/>
<person name="Plumb R.W."/>
<person name="Ramsay H."/>
<person name="Ramsey Y."/>
<person name="Rogers L."/>
<person name="Ross M.T."/>
<person name="Scott C.E."/>
<person name="Sehra H.K."/>
<person name="Skuce C.D."/>
<person name="Smalley S."/>
<person name="Smith M.L."/>
<person name="Soderlund C."/>
<person name="Spragon L."/>
<person name="Steward C.A."/>
<person name="Sulston J.E."/>
<person name="Swann R.M."/>
<person name="Vaudin M."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="Whiteley M.N."/>
<person name="Willey D.L."/>
<person name="Williams L."/>
<person name="Williams S.A."/>
<person name="Williamson H."/>
<person name="Wilmer T.E."/>
<person name="Wilming L."/>
<person name="Wright C.L."/>
<person name="Hubbard T."/>
<person name="Bentley D.R."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Shimizu N."/>
<person name="Minoshima S."/>
<person name="Kawasaki K."/>
<person name="Sasaki T."/>
<person name="Asakawa S."/>
<person name="Kudoh J."/>
<person name="Shintani A."/>
<person name="Shibuya K."/>
<person name="Yoshizaki Y."/>
<person name="Aoki N."/>
<person name="Mitsuyama S."/>
<person name="Roe B.A."/>
<person name="Chen F."/>
<person name="Chu L."/>
<person name="Crabtree J."/>
<person name="Deschamps S."/>
<person name="Do A."/>
<person name="Do T."/>
<person name="Dorman A."/>
<person name="Fang F."/>
<person name="Fu Y."/>
<person name="Hu P."/>
<person name="Hua A."/>
<person name="Kenton S."/>
<person name="Lai H."/>
<person name="Lao H.I."/>
<person name="Lewis J."/>
<person name="Lewis S."/>
<person name="Lin S.-P."/>
<person name="Loh P."/>
<person name="Malaj E."/>
<person name="Nguyen T."/>
<person name="Pan H."/>
<person name="Phan S."/>
<person name="Qi S."/>
<person name="Qian Y."/>
<person name="Ray L."/>
<person name="Ren Q."/>
<person name="Shaull S."/>
<person name="Sloan D."/>
<person name="Song L."/>
<person name="Wang Q."/>
<person name="Wang Y."/>
<person name="Wang Z."/>
<person name="White J."/>
<person name="Willingham D."/>
<person name="Wu H."/>
<person name="Yao Z."/>
<person name="Zhan M."/>
<person name="Zhang G."/>
<person name="Chissoe S."/>
<person name="Murray J."/>
<person name="Miller N."/>
<person name="Minx P."/>
<person name="Fulton R."/>
<person name="Johnson D."/>
<person name="Bemis G."/>
<person name="Bentley D."/>
<person name="Bradshaw H."/>
<person name="Bourne S."/>
<person name="Cordes M."/>
<person name="Du Z."/>
<person name="Fulton L."/>
<person name="Goela D."/>
<person name="Graves T."/>
<person name="Hawkins J."/>
<person name="Hinds K."/>
<person name="Kemp K."/>
<person name="Latreille P."/>
<person name="Layman D."/>
<person name="Ozersky P."/>
<person name="Rohlfing T."/>
<person name="Scheet P."/>
<person name="Walker C."/>
<person name="Wamsley A."/>
<person name="Wohldmann P."/>
<person name="Pepin K."/>
<person name="Nelson J."/>
<person name="Korf I."/>
<person name="Bedell J.A."/>
<person name="Hillier L.W."/>
<person name="Mardis E."/>
<person name="Waterston R."/>
<person name="Wilson R."/>
<person name="Emanuel B.S."/>
<person name="Shaikh T."/>
<person name="Kurahashi H."/>
<person name="Saitta S."/>
<person name="Budarf M.L."/>
<person name="McDermid H.E."/>
<person name="Johnson A."/>
<person name="Wong A.C.C."/>
<person name="Morrow B.E."/>
<person name="Edelmann L."/>
<person name="Kim U.J."/>
<person name="Shizuya H."/>
<person name="Simon M.I."/>
<person name="Dumanski J.P."/>
<person name="Peyrard M."/>
<person name="Kedra D."/>
<person name="Seroussi E."/>
<person name="Fransson I."/>
<person name="Tapia I."/>
<person name="Bruder C.E."/>
<person name="O'Brien K.P."/>
<person name="Wilkinson P."/>
<person name="Bodenteich A."/>
<person name="Hartman K."/>
<person name="Hu X."/>
<person name="Khan A.S."/>
<person name="Lane L."/>
<person name="Tilahun Y."/>
<person name="Wright H."/>
</authorList>
<dbReference type="PubMed" id="10591208"/>
<dbReference type="DOI" id="10.1038/990031"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Brain</tissue>
<tissue>Kidney</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="1994" name="Proc. Natl. Acad. Sci. U.S.A." volume="91" first="2587" last="2591">
<title>RanGAP1 induces GTPase activity of nuclear Ras-related Ran.</title>
<authorList>
<person name="Bischoff F.R."/>
<person name="Klebe C."/>
<person name="Kretschmer J."/>
<person name="Wittinghofer A."/>
<person name="Ponstingl H."/>
</authorList>
<dbReference type="PubMed" id="8146159"/>
<dbReference type="DOI" id="10.1073/pnas.91.7.2587"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1995" name="Mol. Cell. Biol." volume="15" first="2117" last="2124">
<title>Separate domains of the Ran GTPase interact with different factors to regulate nuclear protein import and RNA processing.</title>
<authorList>
<person name="Ren M."/>
<person name="Villamarin A."/>
<person name="Shih A."/>
<person name="Coutavas E."/>
<person name="Moore M.S."/>
<person name="Locurcio M."/>
<person name="Clarke V."/>
<person name="Oppenheim J.D."/>
<person name="D'Eustachio P."/>
<person name="Rush M.G."/>
</authorList>
<dbReference type="PubMed" id="7891706"/>
<dbReference type="DOI" id="10.1128/mcb.15.4.2117"/>
</citation>
<scope>INTERACTION WITH RAN</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1996" name="Gene" volume="180" first="7" last="11">
<title>Ubiquitous expression and testis-specific alternative polyadenylation of mRNA for the human Ran GTPase activator RanGAP1.</title>
<authorList>
<person name="Krebber H."/>
<person name="Ponstingl H."/>
</authorList>
<dbReference type="PubMed" id="8973340"/>
<dbReference type="DOI" id="10.1016/s0378-1119(96)00389-7"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1996" name="EMBO J." volume="15" first="5584" last="5594">
<title>Identification of different roles for RanGDP and RanGTP in nuclear protein import.</title>
<authorList>
<person name="Goerlich D."/>
<person name="Pante N."/>
<person name="Kutay U."/>
<person name="Aebi U."/>
<person name="Bischoff F.R."/>
</authorList>
<dbReference type="PubMed" id="8896452"/>
<dbReference type="DOI" id="10.1002/j.1460-2075.1996.tb00943.x"/>
</citation>
<scope>INTERACTION WITH RAN</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2002" name="J. Cell Biol." volume="156" first="595" last="602">
<title>SUMO-1 targets RanGAP1 to kinetochores and mitotic spindles.</title>
<authorList>
<person name="Joseph J."/>
<person name="Tan S.-H."/>
<person name="Karpova T.S."/>
<person name="McNally J.G."/>
<person name="Dasso M."/>
</authorList>
<dbReference type="PubMed" id="11854305"/>
<dbReference type="DOI" id="10.1083/jcb.200110109"/>
</citation>
<scope>SUMOYLATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF LYS-524</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2004" name="J. Cell Biol." volume="164" first="965" last="971">
<title>RanGAP1*SUMO1 is phosphorylated at the onset of mitosis and remains associated with RanBP2 upon NPC disassembly.</title>
<authorList>
<person name="Swaminathan S."/>
<person name="Kiendl F."/>
<person name="Koerner R."/>
<person name="Lupetti R."/>
<person name="Hengst L."/>
<person name="Melchior F."/>
</authorList>
<dbReference type="PubMed" id="15037602"/>
<dbReference type="DOI" id="10.1083/jcb.200309126"/>
</citation>
<scope>PHOSPHORYLATION AT THR-409; SER-428 AND SER-442</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>SUMOYLATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH SUMO1; RANBP2 AND UBE2I</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2004" name="Mol. Cell. Biol." volume="24" first="1155" last="1167">
<title>RanBP2/Nup358 provides a major binding site for NXF1-p15 dimers at the nuclear pore complex and functions in nuclear mRNA export.</title>
<authorList>
<person name="Forler D."/>
<person name="Rabut G."/>
<person name="Ciccarelli F.D."/>
<person name="Herold A."/>
<person name="Koecher T."/>
<person name="Niggeweg R."/>
<person name="Bork P."/>
<person name="Ellenberg J."/>
<person name="Izaurralde E."/>
</authorList>
<dbReference type="PubMed" id="14729961"/>
<dbReference type="DOI" id="10.1128/mcb.24.3.1155-1167.2004"/>
</citation>
<scope>IDENTIFICATION IN A COMPLEX WITH RANBP2; NXF1 AND NXT1</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2005" name="Cell Struct. Funct." volume="30" first="69" last="80">
<title>Phosphorylation of RanGAP1 stabilizes its interaction with Ran and RanBP1.</title>
<authorList>
<person name="Takeda E."/>
<person name="Hieda M."/>
<person name="Katahira J."/>
<person name="Yoneda Y."/>
</authorList>
<dbReference type="PubMed" id="16428860"/>
<dbReference type="DOI" id="10.1247/csf.30.69"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH RAN AND RANBP1</scope>
<scope>PHOSPHORYLATION AT SER-358</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>SUMOYLATION</scope>
<scope>MUTAGENESIS OF ARG-91; SER-356 AND SER-358</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-442</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="5081" last="5089">
<title>Nuclear tumor necrosis factor receptor-associated factor 6 in lymphoid cells negatively regulates c-Myb-mediated transactivation through small ubiquitin-related modifier-1 modification.</title>
<authorList>
<person name="Pham L.V."/>
<person name="Zhou H.J."/>
<person name="Lin-Lee Y.C."/>
<person name="Tamayo A.T."/>
<person name="Yoshimura L.C."/>
<person name="Fu L."/>
<person name="Darnay B.G."/>
<person name="Ford R.J."/>
</authorList>
<dbReference type="PubMed" id="18093978"/>
<dbReference type="DOI" id="10.1074/jbc.m706307200"/>
</citation>
<scope>INTERACTION WITH TRAF6</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-358; SER-428 AND SER-442</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-428; SER-435; THR-436 AND SER-442</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-524</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="19324" last="19329">
<title>In vivo identification of sumoylation sites by a signature tag and cysteine-targeted affinity purification.</title>
<authorList>
<person name="Blomster H.A."/>
<person name="Imanishi S.Y."/>
<person name="Siimes J."/>
<person name="Kastu J."/>
<person name="Morrice N.A."/>
<person name="Eriksson J.E."/>
<person name="Sistonen L."/>
</authorList>
<dbReference type="PubMed" id="20388717"/>
<dbReference type="DOI" id="10.1074/jbc.m110.106955"/>
</citation>
<scope>SUMOYLATION AT LYS-8 AND LYS-524</scope>
<scope>ACETYLATION AT ALA-2</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-428 AND SER-442</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-442</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-24; SER-301 AND SER-442</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="26">
<citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="927" last="936">
<title>Uncovering global SUMOylation signaling networks in a site-specific manner.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="D'Souza R.C."/>
<person name="Yang B."/>
<person name="Verlaan-de Vries M."/>
<person name="Mann M."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25218447"/>
<dbReference type="DOI" id="10.1038/nsmb.2890"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-524</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2014" name="Proc. Natl. Acad. Sci. U.S.A." volume="111" first="12432" last="12437">
<title>Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli.</title>
<authorList>
<person name="Impens F."/>
<person name="Radoshevich L."/>
<person name="Cossart P."/>
<person name="Ribet D."/>
</authorList>
<dbReference type="PubMed" id="25114211"/>
<dbReference type="DOI" id="10.1073/pnas.1413825111"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-524</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2015" name="Cell Rep." volume="10" first="1778" last="1791">
<title>SUMO-2 orchestrates chromatin modifiers in response to DNA damage.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Treffers L.W."/>
<person name="Verlaan-de Vries M."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25772364"/>
<dbReference type="DOI" id="10.1016/j.celrep.2015.02.033"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-524</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2015" name="J. Biol. Chem." volume="290" first="25620" last="25635">
<title>MYCBP2 is a guanosine exchange factor for Ran protein and determines its localization in neurons of dorsal root ganglia.</title>
<authorList>
<person name="Doerr A."/>
<person name="Pierre S."/>
<person name="Zhang D.D."/>
<person name="Henke M."/>
<person name="Holland S."/>
<person name="Scholich K."/>
</authorList>
<dbReference type="PubMed" id="26304119"/>
<dbReference type="DOI" id="10.1074/jbc.m115.646901"/>
</citation>
<scope>INTERACTION WITH MYCBP2</scope>
<scope>SUMOYLATION</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2015" name="Mol. Cell. Proteomics" volume="14" first="1419" last="1434">
<title>System-wide analysis of SUMOylation dynamics in response to replication stress reveals novel small ubiquitin-like modified target proteins and acceptor lysines relevant for genome stability.</title>
<authorList>
<person name="Xiao Z."/>
<person name="Chang J.G."/>
<person name="Hendriks I.A."/>
<person name="Sigurdsson J.O."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25755297"/>
<dbReference type="DOI" id="10.1074/mcp.o114.044792"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-524</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2016" name="Nat. Commun." volume="7" first="11482" last="11482">
<title>The RanBP2/RanGAP1*SUMO1/Ubc9 SUMO E3 ligase is a disassembly machine for Crm1-dependent nuclear export complexes.</title>
<authorList>
<person name="Ritterhoff T."/>
<person name="Das H."/>
<person name="Hofhaus G."/>
<person name="Schroeder R.R."/>
<person name="Flotho A."/>
<person name="Melchior F."/>
</authorList>
<dbReference type="PubMed" id="27160050"/>
<dbReference type="DOI" id="10.1038/ncomms11482"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH XPO1; RAN; RANBP2; SUMO1 AND UBE2I</scope>
<scope>SUMOYLATION</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-8; LYS-15; LYS-279; LYS-452; LYS-524 AND LYS-586</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="33" evidence="1">
<citation type="journal article" date="2005" name="Nature" volume="435" first="687" last="692">
<title>Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex.</title>
<authorList>
<person name="Reverter D."/>
<person name="Lima C.D."/>
</authorList>
<dbReference type="PubMed" id="15931224"/>
<dbReference type="DOI" id="10.1038/nature03588"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.01 ANGSTROMS) OF 418-587 IN COMPLEX WITH SUMO1; RANBP2 AND UBE2I</scope>
</reference>
<reference key="34" evidence="4">
<citation type="journal article" date="2006" name="Nat. Struct. Mol. Biol." volume="13" first="1069" last="1077">
<title>SUMO protease SENP1 induces isomerization of the scissile peptide bond.</title>
<authorList>
<person name="Shen L."/>
<person name="Tatham M.H."/>
<person name="Dong C."/>
<person name="Zagorska A."/>
<person name="Naismith J.H."/>
<person name="Hay R.T."/>
</authorList>
<dbReference type="PubMed" id="17099698"/>
<dbReference type="DOI" id="10.1038/nsmb1172"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.77 ANGSTROMS) OF 432-587 IN COMPLEX WITH SUMO1 AND SENP1</scope>
</reference>
<reference key="35" evidence="5 6 7">
<citation type="journal article" date="2012" name="J. Biol. Chem." volume="287" first="4740" last="4751">
<title>Determinants of small ubiquitin-like modifier 1 (SUMO1) protein specificity, E3 ligase, and SUMO-RanGAP1 binding activities of nucleoporin RanBP2.</title>
<authorList>
<person name="Gareau J.R."/>
<person name="Reverter D."/>
<person name="Lima C.D."/>
</authorList>
<dbReference type="PubMed" id="22194619"/>
<dbReference type="DOI" id="10.1074/jbc.m111.321141"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.29 ANGSTROMS) OF 419-587 IN COMPLEXES WITH RANBP2; SUMO1; SUMO2 AND UBE2I</scope>
</reference>
<comment type="function">
<text evidence="25 30 32 33">GTPase activator for RAN (PubMed:8146159, PubMed:8896452, PubMed:16428860). Converts cytoplasmic GTP-bound RAN to GDP-bound RAN, which is essential for RAN-mediated nuclear import and export (PubMed:8896452, PubMed:27160050). Mediates dissociation of cargo from nuclear export complexes containing XPO1, RAN and RANBP2 after nuclear export (PubMed:27160050).</text>
</comment>
<comment type="subunit">
<text evidence="22 23 24 25 26 27 29 30 31 32 33">Homodimer (PubMed:8146159). Interacts with RAN (PubMed:7891706, PubMed:8896452, PubMed:16428860). Forms a complex with RANBP2/NUP358, NXF1 and NXT1 (PubMed:14729961). Forms a tight complex in association with RANBP2/NUP358 and UBE2I/UBC9, the ubiquitin-conjugating enzyme E2 (PubMed:15037602, PubMed:27160050, PubMed:15931224, PubMed:22194619). Interacts with UBE2I; the interaction conjugates SUMO1 to RANGAP1, and subsequently stabilizes interactions of sumoylated RANGAP1 with RANBP2/NUP358 (PubMed:15037602, PubMed:27160050, PubMed:15931224). The complex composed of RANBP2, SUMO1, RANGAP1 and UBE2I associates with nuclear pore complexes (PubMed:15037602, PubMed:15931224). Identified in a complex composed of RAN, RANBP2, sumoylated RANGAP1, UBE2I and XPO1 (PubMed:27160050). Identified in a complex composed of RAN, RANGAP1 and RANBP1 (PubMed:16428860). Interacts with TRAF6 (PubMed:18093978). Interacts with SUMO1 and SENP1 (PubMed:17099698). Interacts (when sumoylated) with MYCBP2; interaction inhibits MYCBP2 E3 ubiquitin-protein ligase activity and promotes MYCBP2 translocation to the nucleus (PubMed:26304119).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-396091">
<id>P46060</id>
</interactant>
<interactant intactId="EBI-80140">
<id>P63165</id>
<label>SUMO1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>13</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-396091">
<id>P46060</id>
</interactant>
<interactant intactId="EBI-80168">
<id>P63279</id>
<label>UBE2I</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="23 37">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="32">Nucleus</location>
<location evidence="32">Nucleoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="21 23">Nucleus envelope</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="21">Chromosome</location>
<location evidence="21">Centromere</location>
<location evidence="21">Kinetochore</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="21 23">Cytoplasm</location>
<location evidence="21 23">Cytoskeleton</location>
<location evidence="21 23">Spindle</location>
</subcellularLocation>
<text evidence="21 23">Cytoplasmic during interphase. Detected at the nuclear envelope during interphase (PubMed:11854305, PubMed:15037602). Targeted to the nuclear pores after sumoylation (PubMed:11854305). During mitosis, associates with mitotic spindles, but is essentially not detected at the spindle poles (PubMed:11854305, PubMed:15037602). Association with kinetochores appears soon after nuclear envelope breakdown and persists until late anaphase (PubMed:11854305). Mitotic location also requires sumoylation (PubMed:11854305).</text>
</comment>
<comment type="tissue specificity">
<text evidence="34">Highly expressed in brain, thymus and testis.</text>
</comment>
<comment type="PTM">
<text evidence="23">Phosphorylation occurs before nuclear envelope breakdown and continues throughout mitosis. Phosphorylated by the M-phase kinase cyclin B/Cdk1, in vitro. Differential timimg of dephosphorylation occurs during phases of mitosis. The phosphorylated form remains associated with RANBP2/NUP358 and the SUMO E2-conjugating enzyme, UBE2I, on nuclear pore complex (NPC) diassembly and during mitosis.</text>
</comment>
<comment type="PTM">
<text evidence="21 23 25 28 29 36">Sumoylated (PubMed:11854305, PubMed:15037602, PubMed:26304119, PubMed:27160050). Sumoylation is necessary for targeting to the nuclear envelope (NE), and for association with mitotic spindles and kinetochores during mitosis (PubMed:11854305). Also required for interaction with RANBP2 and is mediated by UBE2I (PubMed:27160050).</text>
</comment>
<comment type="similarity">
<text evidence="35">Belongs to the RNA1 family.</text>
</comment>
<comment type="sequence caution" evidence="35">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAB47464" version="1"/>
</conflict>
</comment>
<dbReference type="EMBL" id="X82260">
<property type="protein sequence ID" value="CAA57714.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB058738">
<property type="protein sequence ID" value="BAB47464.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CR456557">
<property type="protein sequence ID" value="CAG30443.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL035681">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC014044">
<property type="protein sequence ID" value="AAH14044.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC041396">
<property type="protein sequence ID" value="AAH41396.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS14012.1"/>
<dbReference type="PIR" id="JC5300">
<property type="entry name" value="JC5300"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001265580.1">
<property type="nucleotide sequence ID" value="NM_001278651.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001304859.1">
<property type="nucleotide sequence ID" value="NM_001317930.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_002874.1">
<property type="nucleotide sequence ID" value="NM_002883.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006724352.1">
<property type="nucleotide sequence ID" value="XM_006724289.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011528596.1">
<property type="nucleotide sequence ID" value="XM_011530294.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011528597.1">
<property type="nucleotide sequence ID" value="XM_011530295.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016884382.1">
<property type="nucleotide sequence ID" value="XM_017028893.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016884383.1">
<property type="nucleotide sequence ID" value="XM_017028894.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016884384.1">
<property type="nucleotide sequence ID" value="XM_017028895.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016884385.1">
<property type="nucleotide sequence ID" value="XM_017028896.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016884386.1">
<property type="nucleotide sequence ID" value="XM_017028897.1"/>
</dbReference>
<dbReference type="PDB" id="1Z5S">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.01"/>
<property type="chains" value="C=418-587"/>
</dbReference>
<dbReference type="PDB" id="2GRN">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="B=419-587"/>
</dbReference>
<dbReference type="PDB" id="2GRO">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="B=419-587"/>
</dbReference>
<dbReference type="PDB" id="2GRP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.05"/>
<property type="chains" value="B=419-587"/>
</dbReference>
<dbReference type="PDB" id="2GRQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="B=419-587"/>
</dbReference>
<dbReference type="PDB" id="2GRR">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.30"/>
<property type="chains" value="B=419-587"/>
</dbReference>
<dbReference type="PDB" id="2IO2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="C=418-587"/>
</dbReference>
<dbReference type="PDB" id="2IO3">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="C=418-587"/>
</dbReference>
<dbReference type="PDB" id="2IY0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.77"/>
<property type="chains" value="C=432-587"/>
</dbReference>
<dbReference type="PDB" id="3UIN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="C=419-587"/>
</dbReference>
<dbReference type="PDB" id="3UIO">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="C=419-587"/>
</dbReference>
<dbReference type="PDB" id="3UIP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.29"/>
<property type="chains" value="C=419-587"/>
</dbReference>
<dbReference type="PDB" id="5D2M">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="C/F=418-587"/>
</dbReference>
<dbReference type="PDBsum" id="1Z5S"/>
<dbReference type="PDBsum" id="2GRN"/>
<dbReference type="PDBsum" id="2GRO"/>
<dbReference type="PDBsum" id="2GRP"/>
<dbReference type="PDBsum" id="2GRQ"/>
<dbReference type="PDBsum" id="2GRR"/>
<dbReference type="PDBsum" id="2IO2"/>
<dbReference type="PDBsum" id="2IO3"/>
<dbReference type="PDBsum" id="2IY0"/>
<dbReference type="PDBsum" id="3UIN"/>
<dbReference type="PDBsum" id="3UIO"/>
<dbReference type="PDBsum" id="3UIP"/>
<dbReference type="PDBsum" id="5D2M"/>
<dbReference type="BMRB" id="P46060"/>
<dbReference type="SMR" id="P46060"/>
<dbReference type="BioGRID" id="111840">
<property type="interactions" value="176"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-4747">
<property type="entry name" value="SUMO1 E3 ligase (RANBP2) complex"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-4922">
<property type="entry name" value="SUMO2 E3 ligase (RANBP2) complex"/>
</dbReference>
<dbReference type="DIP" id="DIP-29079N"/>
<dbReference type="IntAct" id="P46060">
<property type="interactions" value="73"/>
</dbReference>
<dbReference type="MINT" id="P46060"/>
<dbReference type="STRING" id="9606.ENSP00000401470"/>
<dbReference type="TCDB" id="1.I.1.1.3">
<property type="family name" value="the nuclear pore complex (npc) family"/>
</dbReference>
<dbReference type="iPTMnet" id="P46060"/>
<dbReference type="MetOSite" id="P46060"/>
<dbReference type="PhosphoSitePlus" id="P46060"/>
<dbReference type="SwissPalm" id="P46060"/>
<dbReference type="BioMuta" id="RANGAP1"/>
<dbReference type="DMDM" id="1172922"/>
<dbReference type="EPD" id="P46060"/>
<dbReference type="jPOST" id="P46060"/>
<dbReference type="MassIVE" id="P46060"/>
<dbReference type="MaxQB" id="P46060"/>
<dbReference type="PaxDb" id="P46060"/>
<dbReference type="PeptideAtlas" id="P46060"/>
<dbReference type="PRIDE" id="P46060"/>
<dbReference type="ProteomicsDB" id="55712"/>
<dbReference type="Antibodypedia" id="3803">
<property type="antibodies" value="374 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="5905"/>
<dbReference type="Ensembl" id="ENST00000356244">
<property type="protein sequence ID" value="ENSP00000348577"/>
<property type="gene ID" value="ENSG00000100401"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000405486">
<property type="protein sequence ID" value="ENSP00000385866"/>
<property type="gene ID" value="ENSG00000100401"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000455915">
<property type="protein sequence ID" value="ENSP00000401470"/>
<property type="gene ID" value="ENSG00000100401"/>
</dbReference>
<dbReference type="GeneID" id="5905"/>
<dbReference type="KEGG" id="hsa:5905"/>
<dbReference type="UCSC" id="uc003azs.5">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="5905"/>
<dbReference type="DisGeNET" id="5905"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000100401.19"/>
<dbReference type="GeneCards" id="RANGAP1"/>
<dbReference type="HGNC" id="HGNC:9854">
<property type="gene designation" value="RANGAP1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000100401">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="602362">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P46060"/>
<dbReference type="OpenTargets" id="ENSG00000100401"/>
<dbReference type="PharmGKB" id="PA34216"/>
<dbReference type="eggNOG" id="KOG1909">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00440000039203"/>
<dbReference type="HOGENOM" id="CLU_028747_2_0_1"/>
<dbReference type="InParanoid" id="P46060"/>
<dbReference type="KO" id="K14319"/>
<dbReference type="OMA" id="WGVDELD"/>
<dbReference type="OrthoDB" id="1357476at2759"/>
<dbReference type="PhylomeDB" id="P46060"/>
<dbReference type="TreeFam" id="TF318283"/>
<dbReference type="PathwayCommons" id="P46060"/>
<dbReference type="Reactome" id="R-HSA-141444">
<property type="pathway name" value="Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-165054">
<property type="pathway name" value="Rev-mediated nuclear export of HIV RNA"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2467813">
<property type="pathway name" value="Separation of Sister Chromatids"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2500257">
<property type="pathway name" value="Resolution of Sister Chromatid Cohesion"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3108232">
<property type="pathway name" value="SUMO E3 ligases SUMOylate target proteins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-4615885">
<property type="pathway name" value="SUMOylation of DNA replication proteins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5663220">
<property type="pathway name" value="RHO GTPases Activate Formins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-68877">
<property type="pathway name" value="Mitotic Prometaphase"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9615933">
<property type="pathway name" value="Postmitotic nuclear pore complex (NPC) reformation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9648025">
<property type="pathway name" value="EML4 and NUDC in mitotic spindle formation"/>
</dbReference>
<dbReference type="SIGNOR" id="P46060"/>
<dbReference type="BioGRID-ORCS" id="5905">
<property type="hits" value="754 hits in 876 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="RANGAP1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P46060"/>
<dbReference type="GeneWiki" id="RANGAP1"/>
<dbReference type="GenomeRNAi" id="5905"/>
<dbReference type="Pharos" id="P46060">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:P46060"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 22"/>
</dbReference>
<dbReference type="RNAct" id="P46060">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000100401">
<property type="expression patterns" value="Expressed in left testis and 233 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P46060">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P46060">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0016235">
<property type="term" value="C:aggresome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:1904115">
<property type="term" value="C:axon cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000777">
<property type="term" value="C:condensed chromosome kinetochore"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:1990723">
<property type="term" value="C:cytoplasmic periphery of the nuclear pore complex"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0030425">
<property type="term" value="C:dendrite"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043231">
<property type="term" value="C:intracellular membrane-bounded organelle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0072686">
<property type="term" value="C:mitotic spindle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005635">
<property type="term" value="C:nuclear envelope"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031965">
<property type="term" value="C:nuclear membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005643">
<property type="term" value="C:nuclear pore"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0044614">
<property type="term" value="C:nuclear pore cytoplasmic filaments"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="FlyBase"/>
</dbReference>
<dbReference type="GO" id="GO:0045296">
<property type="term" value="F:cadherin binding"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005096">
<property type="term" value="F:GTPase activator activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008536">
<property type="term" value="F:Ran GTPase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="FlyBase"/>
</dbReference>
<dbReference type="GO" id="GO:0031625">
<property type="term" value="F:ubiquitin protein ligase binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0090630">
<property type="term" value="P:activation of GTPase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1904117">
<property type="term" value="P:cellular response to vasopressin"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046826">
<property type="term" value="P:negative regulation of protein export from nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016925">
<property type="term" value="P:protein sumoylation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0048678">
<property type="term" value="P:response to axon injury"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="Gene3D" id="1.25.40.200">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.80.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR001611">
<property type="entry name" value="Leu-rich_rpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR032675">
<property type="entry name" value="LRR_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR009109">
<property type="entry name" value="Ran_GTPase_activating_1_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR036720">
<property type="entry name" value="RanGAP1_C_sf"/>
</dbReference>
<dbReference type="Pfam" id="PF13516">
<property type="entry name" value="LRR_6"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="Pfam" id="PF07834">
<property type="entry name" value="RanGAP1_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF69099">
<property type="entry name" value="SSF69099"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0137">Centromere</keyword>
<keyword id="KW-0158">Chromosome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0206">Cytoskeleton</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0343">GTPase activation</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0995">Kinetochore</keyword>
<keyword id="KW-0433">Leucine-rich repeat</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="initiator methionine" description="Removed" evidence="28">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Ran GTPase-activating protein 1" id="PRO_0000056737">
<location>
<begin position="2"/>
<end position="587"/>
</location>
</feature>
<feature type="repeat" description="LRR 1">
<location>
<begin position="48"/>
<end position="71"/>
</location>
</feature>
<feature type="repeat" description="LRR 2">
<location>
<begin position="111"/>
<end position="134"/>
</location>
</feature>
<feature type="repeat" description="LRR 3">
<location>
<begin position="207"/>
<end position="230"/>
</location>
</feature>
<feature type="repeat" description="LRR 4">
<location>
<begin position="235"/>
<end position="258"/>
</location>
</feature>
<feature type="repeat" description="LRR 5">
<location>
<begin position="292"/>
<end position="319"/>
</location>
</feature>
<feature type="repeat" description="LRR 6">
<location>
<begin position="320"/>
<end position="343"/>
</location>
</feature>
<feature type="short sequence motif" description="SUMO conjugation">
<location>
<begin position="523"/>
<end position="526"/>
</location>
</feature>
<feature type="compositionally biased region" description="Asp/Glu-rich (highly acidic)">
<location>
<begin position="359"/>
<end position="399"/>
</location>
</feature>
<feature type="compositionally biased region" description="Asp/Glu-rich (highly acidic)">
<location>
<begin position="359"/>
<end position="397"/>
</location>
</feature>
<feature type="site" description="Hydrophobic interaction with UBE2I" evidence="20">
<location>
<position position="562"/>
</location>
</feature>
<feature type="site" description="Hydrophobic interaction with UBE2I" evidence="20">
<location>
<position position="565"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylalanine" evidence="28">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="24"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="301"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9 25">
<location>
<position position="358"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by CDK2" evidence="23">
<location>
<position position="409"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9 11 12 23">
<location>
<position position="428"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="435"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="11">
<location>
<position position="436"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 9 11 12 13 14 23">
<location>
<position position="442"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="10">
<location>
<position position="524"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate">
<location>
<position position="8"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="19">
<location>
<position position="8"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="19">
<location>
<position position="15"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="19">
<location>
<position position="279"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="19">
<location>
<position position="452"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate" evidence="15 21">
<location>
<position position="524"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="15 16 17 18 19">
<location>
<position position="524"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="19">
<location>
<position position="586"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2229752." id="VAR_029240">
<original>E</original>
<variation>Q</variation>
<location>
<position position="133"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes RAN GTPase activation." evidence="25">
<original>R</original>
<variation>A</variation>
<location>
<position position="91"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on phosphorylation." evidence="25">
<original>S</original>
<variation>A</variation>
<location>
<position position="356"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly decreased phosphorylation. No effect on sumoylation." evidence="25">
<original>S</original>
<variation>A</variation>
<location>
<position position="358"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of cross-link to SUMO1. Abolishes association with nuclear pores during interphase, and with mitotic spindles during mitosis." evidence="21">
<original>K</original>
<variation>R</variation>
<location>
<position position="524"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="434"/>
<end position="439"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="443"/>
<end position="448"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="450"/>
<end position="452"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="453"/>
<end position="459"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="466"/>
<end position="477"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="484"/>
<end position="502"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="503"/>
<end position="507"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="509"/>
<end position="519"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="522"/>
<end position="526"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="536"/>
<end position="545"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="548"/>
<end position="551"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="553"/>
<end position="555"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="556"/>
<end position="564"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="568"/>
<end position="571"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="574"/>
<end position="586"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1Z5S"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2GRR"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2IO2"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2IY0"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3UIN"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3UIO"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3UIP"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25114211"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25218447"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25755297"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25772364"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000250"/>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11854305"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14729961"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15037602"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15931224"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16428860"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17099698"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18093978"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20388717"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26304119"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27160050"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7891706"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8146159"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8896452"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8973340"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000305"/>
<evidence key="36" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="27160050"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="8146159"/>
</source>
</evidence>
<sequence length="587" mass="63542" checksum="3C18068AAC06B98F" modified="1995-11-01" version="1">MASEDIAKLAETLAKTQVAGGQLSFKGKSLKLNTAEDAKDVIKEIEDFDSLEALRLEGNTVGVEAARVIAKALEKKSELKRCHWSDMFTGRLRTEIPPALISLGEGLITAGAQLVELDLSDNAFGPDGVQGFEALLKSSACFTLQELKLNNCGMGIGGGKILAAALTECHRKSSAQGKPLALKVFVAGRNRLENDGATALAEAFRVIGTLEEVHMPQNGINHPGITALAQAFAVNPLLRVINLNDNTFTEKGAVAMAETLKTLRQVEVINFGDCLVRSKGAVAIADAIRGGLPKLKELNLSFCEIKRDAALAVAEAMADKAELEKLDLNGNTLGEEGCEQLQEVLEGFNMAKVLASLSDDEDEEEEEEGEEEEEEAEEEEEEDEEEEEEEEEEEEEEPQQRGQGEKSATPSRKILDPNTGEPAPVLSSPPPADVSTFLAFPSPEKLLRLGPKSSVLIAQQTDTSDPEKVVSAFLKVSSVFKDEATVRMAVQDAVDALMQKAFNSSSFNSNTFLTRLLVHMGLLKSEDKVKAIANLYGPLMALNHMVQQDYFPKALAPLLLAFVTKPNSALESCSFARHSLLQTLYKV</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

